Loading
A phase 2 trial in pancreatic cancer, run by Massachusetts General Hospital, now recruiting.
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury is a phase 2, interventional study registered as NCT04485286 by Massachusetts General Hospital, with a registry enrolment figure of 72 participants, started 2020-07-19 and due to reach its primary completion in 2027-05. Interventions recorded: [68Ga]CBP8. Conditions listed: Lung Cancer; Radiation Fibrosis; Radiation Induced Lung Injury; Pancreas Cancer. Primary outcome: Ability of [68Ga]CBP8 to detect collagen deposition in areas of radiation injury.. Pancreatic eligibility wording from the registry: "Inclusion Criteria for pancreatic cancer subjects:". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.